Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
- Status
- TERMINATED
- Phase
- PHASE1
Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q
- Status
- COMPLETED
- Phase
- PHASE2
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Exjade-Early-Trial
- Status
- TERMINATED
- Phase
- PHASE2
MSC and HSC Coinfusion in Mismatched Minitransplants
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
- Status
- COMPLETED
- Phase
- PHASE2
To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
- Status
- TERMINATED
- Phase
- PHASE4
Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
- Status
- TERMINATED
- Phase
- PHASE1
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
- Status
- COMPLETED
- Phase
- N/A
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
- Status
- COMPLETED
- Phase
- N/A
Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk
- Status
- COMPLETED
- Phase
- N/A
Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
- Status
- COMPLETED
- Phase
- PHASE1